D.Th. Sleijfer
Impact in
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
- Sperm and Testicular Function
- Oncology top 5%
- Lung Cancer Research Studies
Papers in
- Co-authors
- Elisabeth G.E. de Vries (24 shared papers)H. Schraffordt Koops (8 shared papers)Nanno H. Mulder (14 shared papers)Jourik A. Gietema (11 shared papers)Harm Hoekstra (7 shared papers)Pax H.B. Willemse (11 shared papers)Winette T.A. van der Graaf (9 shared papers)NH Mulder (10 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)British Journal of Cancer (8 papers)European Journal of Cancer (6 papers)Annals of Oncology (4 papers)Gynecologic Oncology (3 papers)
- Partner nations
- NetherlandsUnited KingdomUnited States
In The Last Decade
D.Th. Sleijfer
76 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 104
- Reproductive Medicine 326
- Oncology 601
- Surgery 860
- Hematology 173
- Pathology and Forensic Medicine 197
Countries citing papers authored by D.Th. Sleijfer
This map shows the geographic impact of D.Th. Sleijfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.Th. Sleijfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.Th. Sleijfer more than expected).
Fields of papers citing papers by D.Th. Sleijfer
This network shows the impact of papers produced by D.Th. Sleijfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.Th. Sleijfer. The network helps show where D.Th. Sleijfer may publish in the future.
Co-authors
The 25 scholars most cited alongside D.Th. Sleijfer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 235 | |
| 2 | 1979 | 89 | |
| 3 | 1987 | 82 | |
| 4 | 2012 | 81 | |
| 5 | 1989 | 80 | |
| 6 | 1992 | 77 | |
| 7 | 1994 | 76 | |
| 8 | 1992 | 72 | |
| 9 | High-dose etoposide for refractory malignancies: a phase I study. | 1984 | 67 |
| 10 | 2004 | 62 | |
| 11 | 1993 | 59 | |
| 12 | 1987 | 57 | |
| 13 | 1999 | 52 | |
| 14 | 1999 | 51 | |
| 15 | 2004 | 50 | |
| 16 | 1995 | 50 | |
| 17 | 1995 | 48 | |
| 18 | 1997 | 47 | |
| 19 | High-dose cyclophosphamide or melphalan with escalating doses of mitoxantrone and autologous bone marrow transplantation for refractory solid tumors. | 1989 | 47 |
| 20 | 1997 | 37 |
About D.Th. Sleijfer
D.Th. Sleijfer is a scholar working on Surgery, Oncology, Reproductive Medicine, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 78 papers that have together received 2.2k indexed citations. Recurring topics across this work include Testicular diseases and treatments (27 papers), Ovarian cancer diagnosis and treatment (9 papers), Chemotherapy-induced organ toxicity mitigation (8 papers), Sarcoma Diagnosis and Treatment (8 papers), Urologic and reproductive health conditions (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Lung Cancer Research Studies (5 papers) and Hematopoietic Stem Cell Transplantation (4 papers). The work is most often cited by research in Reproductive Medicine (326 citations), Oncology (601 citations), Surgery (860 citations), Hematology (173 citations) and Pathology and Forensic Medicine (197 citations). D.Th. Sleijfer has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Elisabeth G.E. de Vries, H. Schraffordt Koops, Nanno H. Mulder, Jourik A. Gietema, Harm Hoekstra, Pax H.B. Willemse, Winette T.A. van der Graaf, NH Mulder, N. H. Mulder and Pieter E. Postmus. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, European Journal of Cancer, Annals of Oncology and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.